A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Mucositis News
Latest Mucositis News
Kepivance® Reduces Mucositis Associated with High-dose Methotrexate (9/10/2008)

Chlorhexidine or Oral Cooling Decrease Chemotherapy-induced Mucositis (3/31/2008)

Kepivance® May Decrease Oral Mucositis Following High-Dose Chemotherapy (1/8/2007)

Kepivance® Decreases Oral Mucositis in Patients with Metastatic Colorectal Cancer. (11/27/2006)

Kepivance® Reduces Mucositis After Allogeneic Stem Cell Transplantation Without Impact on Acute GVHD (11/9/2006)

Newsletters
Register in our member center today to receive a monthly newsletter with clinical news updates.
Learn More »
More on Mucositis
Review the latest current topics and conference coverage on Mucositis written by thought leaders.
Learn More »
Practice Resources
Learn how to have our news directly fed to your website.
Learn More »

Additional Resources
Information by Cancer Type



© 1998-2007 CancerConsultants.com  All Rights Reserved.